What is Tectonic Therapeutics's net investment in lease?

Tectonic Therapeutics (TECX) reported net investment in lease of $4.11M in Q1 2026.

How has Tectonic Therapeutics's net investment in lease changed year-over-year?

Tectonic Therapeutics's net investment in lease increased by 138.3% year-over-year, from $1.72M to $4.11M.

Tectonic Therapeutics TECX Net Investment in Lease

Net Investment in Lease at other companies

ALN

Alnylam PharmaceuticalsALNY

——

Septerna, Inc.SEPN

——

RegenxbioRGNX

——

Opko HealthOPK

——

Ginkgo BioworksDNA

——

Rigel PharmaceuticalsRIGL

——

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's net investment in lease?: Tectonic Therapeutics (TECX) reported net investment in lease of $4.11M in Q1 2026.
How has Tectonic Therapeutics's net investment in lease changed year-over-year?: Tectonic Therapeutics's net investment in lease increased by 138.3% year-over-year, from $1.72M to $4.11M.